BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 12214244)

  • 21. Cell cycle-dependent phosphorylation of p27 cyclin-dependent kinase (Cdk) inhibitor by cyclin E/Cdk2.
    Morisaki H; Fujimoto A; Ando A; Nagata Y; Ikeda K; Nakanishi M
    Biochem Biophys Res Commun; 1997 Nov; 240(2):386-90. PubMed ID: 9388487
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Cdc2 activation by phosphorylation].
    Yamashita K
    Seikagaku; 1996 May; 68(5):367-71. PubMed ID: 8727661
    [No Abstract]   [Full Text] [Related]  

  • 23. Direct regulation of the centrosome duplication cycle by the p53-p21Waf1/Cip1 pathway.
    Tarapore P; Horn HF; Tokuyama Y; Fukasawa K
    Oncogene; 2001 May; 20(25):3173-84. PubMed ID: 11423967
    [TBL] [Abstract][Full Text] [Related]  

  • 24. E1A modulates phosphorylation of p130 and p107 by differentially regulating the activity of G1/S cyclin/CDK complexes.
    Parreño M; Garriga J; Limón A; Albrecht JH; Graña X
    Oncogene; 2001 Aug; 20(35):4793-806. PubMed ID: 11521191
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reduction of Cdc25A contributes to cyclin E1-Cdk2 inhibition at senescence in human mammary epithelial cells.
    Sandhu C; Donovan J; Bhattacharya N; Stampfer M; Worland P; Slingerland J
    Oncogene; 2000 Nov; 19(47):5314-23. PubMed ID: 11103932
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PKCeta associates with cyclin E/cdk2/p21 complex, phosphorylates p21 and inhibits cdk2 kinase in keratinocytes.
    Kashiwagi M; Ohba M; Watanabe H; Ishino K; Kasahara K; Sanai Y; Taya Y; Kuroki T
    Oncogene; 2000 Dec; 19(54):6334-41. PubMed ID: 11175348
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cdk2-dependent phosphorylation of p27 facilitates its Myc-induced release from cyclin E/cdk2 complexes.
    Müller D; Bouchard C; Rudolph B; Steiner P; Stuckmann I; Saffrich R; Ansorge W; Huttner W; Eilers M
    Oncogene; 1997 Nov; 15(21):2561-76. PubMed ID: 9399644
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The carcinogen 2-acetylaminofluorene inhibits activation and nuclear accumulation of cyclin-dependent kinase 2 in growth-induced rat liver.
    Lindeman B; Skarpen E; Oksvold MP; Huitfeldt HS
    Mol Carcinog; 2000 Mar; 27(3):190-9. PubMed ID: 10708481
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Disruption of the actin cytoskeleton leads to inhibition of mitogen-induced cyclin E expression, Cdk2 phosphorylation, and nuclear accumulation of the retinoblastoma protein-related p107 protein.
    Reshetnikova G; Barkan R; Popov B; Nikolsky N; Chang LS
    Exp Cell Res; 2000 Aug; 259(1):35-53. PubMed ID: 10942577
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of cyclin E in the regulation of entry into S phase.
    Sauer K; Lehner CF
    Prog Cell Cycle Res; 1995; 1():125-39. PubMed ID: 9552358
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of cyclin E and cyclin-dependent kinase 2 correlates with metastasis and prognosis in colorectal carcinoma.
    Li JQ; Miki H; Ohmori M; Wu F; Funamoto Y
    Hum Pathol; 2001 Sep; 32(9):945-53. PubMed ID: 11567224
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activation of cdk4 and cdk2 during rat liver regeneration is associated with intranuclear rearrangements of cyclin-cdk complexes.
    Jaumot M; Estanyol JM; Serratosa J; Agell N; Bachs O
    Hepatology; 1999 Feb; 29(2):385-95. PubMed ID: 9918914
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A mammalian in vitro centriole duplication system: evidence for involvement of CDK2/cyclin E and nucleophosmin/B23 in centrosome duplication.
    Tarapore P; Okuda M; Fukasawa K
    Cell Cycle; 2002 Jan; 1(1):75-81. PubMed ID: 12429912
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of proteasomes in T cell activation and proliferation.
    Wang X; Luo H; Chen H; Duguid W; Wu J
    J Immunol; 1998 Jan; 160(2):788-801. PubMed ID: 9551914
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Regulation of cyclin E and Cdk2 expression at G1/S transition: post-transcriptional reguration mediated by delta FosB].
    Oda S; Nakabeppu Y
    Tanpakushitsu Kakusan Koso; 1996 Sep; 41(12 Suppl):1725-31. PubMed ID: 8890629
    [No Abstract]   [Full Text] [Related]  

  • 36. Cyclin-dependent kinase 2 is essential for meiosis but not for mitotic cell division in mice.
    Ortega S; Prieto I; Odajima J; Martín A; Dubus P; Sotillo R; Barbero JL; Malumbres M; Barbacid M
    Nat Genet; 2003 Sep; 35(1):25-31. PubMed ID: 12923533
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The cell cycle inhibitor p21CIP is phosphorylated by cyclin A-CDK2 complexes.
    Jaumot M; Estañol JM; Casanovas O; Graña X; Agell N; Bachs O
    Biochem Biophys Res Commun; 1997 Dec; 241(2):434-8. PubMed ID: 9425288
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of elevated levels of ornithine decarboxylase on cell cycle progression in skin.
    Gilmour SK; Birchler M; Smith MK; Rayca K; Mostochuk J
    Cell Growth Differ; 1999 Nov; 10(11):739-48. PubMed ID: 10593650
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cdk2 dethroned as master of S phase entry.
    Hinds PW
    Cancer Cell; 2003 Apr; 3(4):305-7. PubMed ID: 12726855
    [TBL] [Abstract][Full Text] [Related]  

  • 40. BCL-x(L) and BCL2 delay Myc-induced cell cycle entry through elevation of p27 and inhibition of G1 cyclin-dependent kinases.
    Greider C; Chattopadhyay A; Parkhurst C; Yang E
    Oncogene; 2002 Nov; 21(51):7765-75. PubMed ID: 12420213
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.